Leukoencephalopathy Following CNS Prophylaxis Therapy in Pediatric Leukemia: MR Imaging Findings.
10.3348/jkrs.2001.45.4.425
- Author:
Jong Sub KIM
1
;
Sang Kwon LEE
;
Tae Hun KIM
;
Yong Joo KIM
;
Duck Sik KANG
;
Soon Hak KWON
;
Keon Soo LEE
Author Information
1. Department of Diagnostic Radiology, College of Medicine, Kyungpook National University.
- Publication Type:Original Article
- Keywords:
Brain, effects of drugs on;
Brain, effects of irradiation on;
Brain, MR;
Brain, white matter
- MeSH:
Child;
Cranial Irradiation;
Diagnosis;
Follow-Up Studies;
Humans;
Leukemia*;
Leukoencephalopathies*;
Magnetic Resonance Imaging*;
Methotrexate;
Retrospective Studies
- From:Journal of the Korean Radiological Society
2001;45(4):425-431
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To evaluate the MR imaging findings and the usefulness of MR imaging in the diagnosis and followup of leukoencephalopathy following CNS prophylaxis therapy in pediatric leukemia. MATERIALS AND METHODS: We retrospectively evaluated the MR imaging findings of eight children with white matter abnormalities on MR out of seventeen acute leukemic patients with various neuropsychiatric symptoms who received intrathecal methotrexate administration, with or without cranial irradiation. In all cases, initial MR was performed within a week of the onset of neuropsychiatric symptoms. Follow-up MR was performed one to sixteen months after initial study, and the MR imaging findings were compared with the initial findings. RESULTS: The initial MR imaging findings were classified into three categories: focal or multifocal white matter abnormalities (3/8), and diffuse white matter abnormalities without enhancement (3/8), and diffuse white matter abnormalities with enhancement (2/8). At follow-up MR, diffuse or focal atrophic changes were noted in all children. White matter abnormalities improved in two out of three patients with focal or multifocal white matter abnormalities. In five with diffuse white matter abnormalities, the extent of these showed no significant change, but contrast enhancement was markedly reduced in two children in whom diffuse white matter abnormalities with enhancement had been demonstrated. CONCLUSION: In pediatric leukemia, the MR imaging findings of leukoencephalopathy following CNS prophylaxis therapy are variable, but are specific with the clinical history of neuropsychiatric symptoms after intrathecal methotrexate administration, with or without cranial irradiation. The MR imaging is valuable in the diagnosis and follow-up of leukoencephalopathy following CNS prophylaxis therapy in pediatric leukemia.
